XT
KAPA

XTX Topco’s Kairos Pharma KAPA Stock Holding History

XTX Topco’s Portfolio KAPA Stock Details KAPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,494
Closed -$34.4K – 4524
2025
Q4 		$34.4K Buy
48,494
+36,086
+291% +$33.8K ﹤0.01% 2927
2025
Q3 		$14.5K Sell
12,408
-50,338
-80% -$57.5K ﹤0.01% 2382
2025
Q2 		$44.5K Buy
+62,746
New +$45.7K ﹤0.01% 2035

Other funds holding KAPA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
SFG
SevenBridge Financial Group Harrisburg, Pennsylvania $680M AUM 30.75% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's KAPA Position: Q1 2026 in Review

XTX Topco sold out of Kairos Pharma (KAPA) in Q1 2026, closing a stake of 48,494 shares — an estimated $34.4K sold.

XTX Topco first reported a position in KAPA in Q2 2025 and held it in 3 quarters. The position peaked at $44.5K in Q2 2025. 11 funds tracked by Wall St. Rank hold KAPA as of Q1 2026.

  • XTX Topco reported no remaining Kairos Pharma position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 48,494 Kairos Pharma shares in Q1 2026, an estimated $34.4K.
  • XTX Topco first reported a position in Kairos Pharma in Q2 2025 and held it in 3 quarters.
  • XTX Topco's Kairos Pharma position peaked at $44.5K in Q2 2025.
  • 11 funds tracked by Wall St. Rank held Kairos Pharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.